PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease.

Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC. · 2021

Read PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease. by Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8082498.txt.

Introduction

Long and co-authors review natural products that act on the PI3K/AKT pathway in Alzheimer's and Parkinson's diseases. Both diseases grow more common as populations age. The PI3K/AKT pathway steers cell growth, death, and metabolism. In neurons, it mediates survival signals and toxic insults alike. Its substrates include FoxO proteins, GSK-3β, and caspase-9.

Many plant-derived compounds switch this pathway on in lab studies. The review gathers those reported in recent years. Each compound is tied to the disease model where it showed protection. Herbal sources recur throughout the survey. The authors argue the pathway offers a rich hunting ground for drugs. Natural products may seed treatments that shield neurons rather than just ease symptoms. They close by urging deeper development of herbal medicine. Rigor in testing those leads is the stated need.

Catalog record

CREATORLong HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE89 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8082498

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease By Hui-Zhi Long, Yan Cheng, Zi-Wei Zhou, Hong-Yu Luo, Dan-Dan Wen, Li-Chen Gao Published in: Frontiers in Pharmacology DOI: 10.3389/fphar.2021.648636 ABSTRACT Abstract Alzheimer’s disease (AD) and Parkinson’s disease (PD) are two typical neurodegenerative diseases that increased with aging. With the emergence of aging population, the health problem and economic burden caused by the two diseases also increase. Phosphatidylinositol 3-kinases/protein kinase B (PI3K/AKT) signaling pathway regulates signal transduction and biological processes such as cell proliferation, apoptosis and metabolism. According to reports, it regulates neurotoxicity and mediates the survival of neurons through different substrates such as forkhead box protein Os (FoxOs), glycogen synthase kinase-3β (GSK-3β), and caspase-9. Accumulating evidences indicate that some natural products can play a neuroprotective role by activating PI3K/AKT pathway, providing an effective resource for the discovery of potential therapeutic drugs. This article reviews the relationship between AKT signaling pathway and AD and PD, and discusses the potential natural products based on the PI3K/AKT signaling pathway to treat two diseases in recent years, hoping to provide guidance and reference for this field. Further development of Chinese herbal medicine is needed to treat these two diseases. Keywords: PI3K/Akt signal pathway, neurodegenerative diseases, Alzheimer’s disease, Parkinson’s disease, natural products, nerve protection INTRODUCTION Neurodegenerative diseases are a kind of diseases that gradually lose the structure or function of neurons, including Parkinson’s disease (PD), Alzheimer’s disease (AD) and Amyotrophic lateral sclerosis (ALS) and so on. These diseases are characterized by progressive degeneration and neuronal necrosis, resulting in cognitive, emotional and behavioral abnormalities (Hetman et al., 2020). With the acceleration of population ages, the number of people suffering from AD and PD is increasing year by year. Up to now, the current treatment strategies of these diseases aim to alleviate symptoms and/or inhibit disease progression without radical cure, posing a serious threat to the quality of patients’ life, hence becoming a global health problem. The high cost of treatment and nursing not only brings great trouble to patients and their families, but also causes great social and economic burden (Batista and Pereira, 2016), making the development of this kind of new drugs an urgent problem in the field of medicine. In addition, abnormal injuries caused by chemotherapy drugs give rise to different degrees of impact on patients’ physical and mental health and quality of life, which have become the direct cause of dosage restriction or discontinuation of some drugs (Vaz and Silvestre, 2020). A systematic review showed that Chinese herbal medicine and its natural active ingredients are of good safety and tolerance in protecting the central nervous system injury, and so that it gets increasing attention by the medical community (Yang et al., 2017). Phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signal pathway has been proved to play an important role in the central nervous system (Matsuda et al., 2019). It has been diffusely studied for its involvement in the physiological processes of central nervous system, such as cell survival, autophagy, neurogenesis, neuronal proliferation and differentiation, and synaptic plasticity. In recent years, a growing number of studies have found that many natural products based on PI3K/AKT signal pathway protect dopaminergic neurons, hippocampal neurons, cortical neurons, and inhibit the activation of microglia, thus playing a role in the prevention and treatment of AD and PD. In this paper, we obtain relevant literature through Pubmed, Web of Science, China National Knowledge Infrastructure (CNKI) and other extensive databases. And we systematically summarize the related studies of natural products for the prevention and treatment of AD and PD based on PI3K/AKT signal pathway. PI3K/AKT SIGNAL PATHWAY: OVERVIEW PI3K: The Key Component Upstream of the Pathway PI3Ks, a family of intracellular lipid kinases, are key elements in the upstream of the PI3K/AKT signaling pathway. PI3Ks are divided into three classes (I-III) according to their structure and substrate selectivity. The most generally studied class I isoforms that are activated by cell surface receptors are heterodimers composed of a regulatory subunit (P85) and a catalytic subunit (P110). The amino terminus of P85 contains a Src Homology 3 (SH3) domain and two proline-rich regions, while the basal terminus contains two SH2 domains and a non-coding region that combine with P110. Besides, class I isoforms are further segmented into class IA (PI3Kα, β and δ) and class IB (PI3Kγ) based on their modes of regulation (Thorpe et al., 2015). Class IA consists of catalytic subunits p110α, β, δ and regulatory subunits p85α, β, γ. Class IB are constituted by a p110γ catalytic subunit coupled with the regulatory isoforms p101 or p87. The differences lie in the way of the activation between the two kinases. PI3Kα, β and δ are activated when extracellular ligands bind to a transmembrane glycoprotein receptor tyrosine kinase (RTK) with enzyme activity, while PI3Kγ is activated by G protein coupled receptors (GPCRs) and Ras family GTP enzymes (Dobbin and Landen, 2013). There are three class II isoforms, PI3KC2α, 2β, 2γ, which may constitutively bind to membranes and require additional activation signals. And the single class III PI3K, vacuolar protein sorting 34 (VPS34), is significant for membrane traffic from the plasma membrane to early endosomes (Sugiyama et al., 2019). AKT: The Core Site of the Pathway Protein kinase B (PKB), a serine/threonine kinase, is considered as one of the most important effector kinase downstream of PI3K and the core of PI3K/AKT signal pathway. Different genes encode three highly homologous subtypes of AKT: AKT1/PKBα, AKT2/PKBβ, and AKT3/PKBγ. Each isoform contains a conserved N-terminal plekstrin homology (PH) domain, a central fragment, and a C-terminal regulatory domain (Hemmings et al., 2004). Membrane translocation in AKT activation is mediated by the PH domain, and AKT activity is weakened due to its mutation or deletion. The structure of the catalytic domain includes an ATP binding site and a threonine residue Thr308 (AKT1-Thr308, AKT2-Thr309, AKT3-Thr305), which is the necessary phosphorylation site for AKT activation. The C-terminal regulatory domain consists of 40 amino acids, holding a hydrophobic region, which containing the second phosphorylation site needed to activate AKT, namely the serine residue Ser473 (AKT1-Ser473, AKT2-Ser474, AKT3-Ser472). Although the three AKT subtypes are highly homologous, each exerts unique physiological functions. AKT1 is broadly distributed in all tissues of the body, mainly involved in cell growth, proliferation, angiogenesis and tumor cell invasiveness (Petrik et al., 2016). Found in Mammalian skeletal muscle, and adipose tissue, AKT2 are confirmed participate in cell growth and proliferation, and mediate glucose homeostasis (Garofalo et al., 2003). Relatively little is known about AKT3, it is crucial for brain development and the survival of malignant glioma cells (Ghoneum and Said, 2019). Signal Regulation of PI3K/AKT Pathway Activation of PI3K/AKT Pathway The activation of PI3K/AKT pathway begins with the activation of PI3K by RTK. Numerous cytokines or growth factors, such as fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF), bind to the plasma membrane receptor RTK in response to stimulation by extracellular ligands, inducing receptor dimerization and cross-phosphorylation of tyrosine residues in intracellular domains. The regulatory subunit P85 binds to the phosphorylated tyrosine residue on the activated receptor through its SH2 domain. The catalytic subunit p110 is then recruited to form a fully active PI3K enzyme. Also, P110 subunit could

Read the complete text